Manufacturer record
Micron Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Micron Pharmaceuticals (Gujarat) were declared Not of Standard Quality between January 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T251209, Montelukast Tablets IP 10 mg (exp Nov 2027). DTL, Thrissur (state lab) found it not of standard quality: The sample does not conform to IP standards with respect to the test Dissolution. Listed in the August 2026 alert.
Records by type
9 records linked to Micron Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Montelukast Tablets IP 10 mg | Batch T251209Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to IP standards with respect to the test DissolutionDissolution | DTL, ThrissurState lab | Aug 2026 |
| Lorazepam Tablets I.P. 2 mg | Batch T240628Mfg Jun 2024 · Exp May 2027 | Dissolution.Dissolution | RDTL ErnakulamState lab | May 2026 |
| Naltrexone HCL Tablets IP 50 mg | Batch T2507109Mfg Jul 2025 · Exp Jun 2027 | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Naltrexone HCL Tablets IP 50 mg | Batch T250651Mfg Jun 2025 · Exp May 2027 | Brittle TabletsOther | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Acetazolamide Tablets IP 250 mg | Batch T 240840Mfg Aug 2024 · Exp Jul 2027 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Feb 2025 |
| Ampicillin Capsules I.P. 250 mg | Batch CB181217Mfg Dec 2018 · Exp Nov 2020 | AssayAssay | CDTL MumbaiCDSCO lab | Jan 2020 |
| Calcium Carbonate Tablets I.P. | Batch T190324Mfg Mar 2019 · Exp Feb 2021 | Uniformity of WeightUniformity of weight/content | CDTL MumbaiCDSCO lab | Sep 2019 |
| Alumina, Magnesium Hydroxide, Magnesium Carbonate and Simethicone Tablets (MILUCID TABLETS) | Batch T170638Mfg Jun 2017 · Exp May 2019 | Assay of Activated DimethiconeAssay | RDTL ChandigarhCDSCO lab | Mar 2019 |
| Ramipril Tablets I.P. 2.5 mg | Batch T180301Mfg Mar 2018 · Exp Feb 2020 | AssayAssay | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.